Drawing for QCOVID

USPTO serial 79310606

QCOVID

Reviewed by CopyMark Law Group

Reg. 6823030Status 700Registered
Filing date
Status date
Registration date
Aug 23, 2022
Examiner
SHANOSKI, JOANNA MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QCOVID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark A. Goldstein

Mark A. Goldstein SoCal IP Law Group LLP310 N. Westlake Blvd., Suite 120Westlake Village, CA 91362UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable predictive modelling computer software for predicting the risk of hospitalisation, mortality and morbidity due to Covid-19; predictive modelling computer software for predicting the risk of hospitalisation, mortality and morbidity due to Covid-19 for use as a downloadable software application; downloadable predictive modelling software for predicting the risk of hospitalisation, mortality and morbidity due to Covid-19; downloadable publications from the Internet, namely, articles in the field of predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19; downloadable predictive modelling databases and electronic data files from the Internet related to the risk of hospitalisation, mortality and morbidity due to Covid-19; downloadable computer software to enable management, storing, searching and retrieval of data for use in the medical and healthcare industries related to predictive modelling of patients data and the associated health risks from Covid-19; downloadable electronic publications provided on-line from databases or the Internet, namely, articles in the field of predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19ACTIVE—
016Printed matter, namely, articles and research papers featuring information related to predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19; operating manuals and instruction booklets in printed form in the field of predictive modelling of computer software for predicting the risk of hospitalisation, mortality and morbidity due to Covid-19ACTIVE—
041Educational and training services namely, seminars and online courses in relation to predictive modelling software of the risk of hospitalisation, mortality and morbidity due to Covid-19; providing on-line, non-downloadable electronic publications namely, articles and research papers in the field of predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19; publication of electronic books and journals on-line in the field of predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19ACTIVE—
042Scientific research related to the diagnosis and risk prediction of Covid-19 to patients; design services for others in the field of medical devices used in the risk prediction of Covid-19 to patients; industrial research and design services in the field of risk prediction of Covid-19 to patients; design and development of software for predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19; advisory services, consultancy services, and design services for others in relation to predictive modelling softwareACTIVE—
044Medical diagnostic testing services for Covid-19; medical diagnostic, monitoring, and reporting services for Covid-19; medical information about Covid-19 provided on-line from a computer database or from the InternetACTIVE—
045Licensing of intellectual property rights for technology use in the diagnosis and risk prediction to patients with Covid-19; licensing of medical devices for use in the diagnosis and risk prediction to patients with Covid-19ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 28, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 1, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 30, 2022FIMPFINAL DISPOSITION PROCESSED—
Nov 23, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 23, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 23, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 7, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 7, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 18, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 2, 2022ALIEASSIGNED TO LIE—
Apr 29, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 29, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Apr 29, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 29, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 29, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 29, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 5, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 18, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Mar 18, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 18, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 18, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 26, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 25, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 25, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 18, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 18, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 18, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 20, 2021RFNTREFUSAL PROCESSED BY IB—
Aug 26, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 26, 2021RFRRREFUSAL PROCESSED BY MPU—
Aug 13, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 12, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2021DOCKASSIGNED TO EXAMINER—
May 18, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
May 14, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 13, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance